# Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques

Study · id `cardio:ct-nct07107971` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07107971](<https://clinicaltrials.gov/study/NCT07107971>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07107971

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

## Technical summary

Registry record NCT07107971. Randomized; no masking; primary purpose treatment. Start 2025-11-04 (actual); primary completion 2028-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT07107971, source copy `cardio:ctgov-nct07107971-2026-01-15`, retrieved 2026-10-26)
- Started: 2025-11-04 (actual) (ClinicalTrials.gov record NCT07107971, source copy `cardio:ctgov-nct07107971-2026-01-15`, retrieved 2026-10-26)
- Primary completion: 2028-01 (anticipated) (ClinicalTrials.gov record NCT07107971, source copy `cardio:ctgov-nct07107971-2026-01-15`, retrieved 2026-10-26)
- Completion: 2033-01 (anticipated) (ClinicalTrials.gov record NCT07107971, source copy `cardio:ctgov-nct07107971-2026-01-15`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT07107971, source copy `cardio:ctgov-nct07107971-2026-01-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07107971-2026-01-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques
- Acronym: DELETE-LRP
- Condition: Coronary Artery Disease
- Condition: Atheroscleroses
- Condition: Cardiovascular Disease
- Condition: Vulnerable Coronary Plaques
- Condition: Vulnerable Plaque
- Condition: Lipid-Rich Atherosclerosis of Coronary Artery
- Condition: Acute Coronary Syndromes (ACS)
- Intervention (Device): Paclitaxel-eluting balloon
- Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (`cardio:org-academisch-medisch-centrum-universiteit-van-amsterdam-amc-662d32`)

## Provenance

Content hash: cadca904f12abedf65c2771045d356f428128031c81f829b3977f5c4d48edd7e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
